Molecular Characterization of the SARS-CoV-2 Helicase and High-Throughput Screening to Identify Small Molecule SARS-CoV-2 Helicase Inhibitors as Anti-Viral Medicines

$492,871ZIAFY2024AGNIH

National Institute On Aging

Investigators

Robert Broshcontact

Linked publications, trials & patents

View original record on NIH RePORTER →

Molecular Characterization of the SARS-CoV-2 Helicase and High-Throughput Screening to Identify Small Molecule SARS-CoV-2 Helicase Inhibitors as Anti-Viral Medicines · GrantIndex